Marilyn C Pike - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Current Rheumatology Reports|May 15, 2012

Data quality challenges in systemic lupus erythematosus trials: how can this be optimized?Marilyn C Pike, Lexy Kelley

BMC Musculoskeletal Disorders|October 12, 2010

Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritisDavid J Hunter, Marilyn C Pike, Beth L Jonas, et al.

Arthritis & Rheumatology (Hoboken, N.J.)|September 7, 2016

Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled TrialsMegan E B Clowse, Daniel J Wallace, Richard A Furie, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Current Rheumatology Reports|May 15, 2012

Data quality challenges in systemic lupus erythematosus trials: how can this be optimized?Marilyn C Pike, Lexy Kelley

BMC Musculoskeletal Disorders|October 12, 2010

Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritisDavid J Hunter, Marilyn C Pike, Beth L Jonas, et al.

Arthritis & Rheumatology (Hoboken, N.J.)|September 7, 2016

Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled TrialsMegan E B Clowse, Daniel J Wallace, Richard A Furie, et al.

Pageof 1